Tenet Healthcare Corporation $THC Stock Position Lessened by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 3.6% during the first quarter, Holdings Channel.com reports. The firm owned 87,502 shares of the company’s stock after selling 3,228 shares during the quarter. New York State Teachers Retirement System’s holdings in Tenet Healthcare were worth $16,513,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Triumph Capital Management acquired a new position in Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management acquired a new stake in shares of Tenet Healthcare in the 4th quarter worth approximately $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the fourth quarter valued at approximately $29,000. Meeder Asset Management Inc. increased its stake in shares of Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter worth approximately $35,000. Institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on THC shares. Robert W. Baird decreased their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Royal Bank Of Canada cut their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Barclays dropped their price target on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Finally, Mizuho raised their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research report on Thursday, March 12th. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $244.32.

Tenet Healthcare Trading Up 0.3%

Shares of THC opened at $204.28 on Friday. The business’s 50-day moving average price is $181.48 and its 200 day moving average price is $197.31. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The stock has a market capitalization of $17.60 billion, a P/E ratio of 10.62, a P/E/G ratio of 1.68 and a beta of 1.27. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.